Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chimerix Inc (NASDAQ:CMRX)

4.87
Delayed Data
As of Dec 05
 +0.17 / +3.62%
Today’s Change
3.50
Today|||52-Week Range
36.97
-45.59%
Year-to-Date
No recent news for Chimerix Inc.

Today’s Trading

Previous close4.70
Today’s open4.75
Day’s range4.74 - 4.95
Volume556,506
Average volume (3 months)521,366
Market cap$217.7M
Dividend yield--
Data as of 3:59pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-48.33%
Earnings growth (this year)+35.43%
Earnings growth (next 5 years)--
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales36.49
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...+0.10+6.33%
--China Health Group I...-0.00-0.90%
OCULOcular Therapeutix I...-0.32-3.37%
STMLStemline Therapeutic...+1.00+8.00%
Data as of 3:59pm ET, 12/05/2016

Financials

Next reporting dateMarch 10, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$10.8M
Annual profit (last year)-$117.4M
Net profit margin-1,090.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
M. Michelle Berrey
Chief Financial Officer, Secretary &
Senior VP
Timothy W. Trost
Corporate headquarters
Durham, North Carolina

Forecasts


Search for Jobs